Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse

This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahuja, Tania, Mgbako, Ofole, Katzman, Caroline, Grossman, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952553/
https://www.ncbi.nlm.nih.gov/pubmed/29854531
http://dx.doi.org/10.1155/2018/9864285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952553/
https://www.ncbi.nlm.nih.gov/pubmed/29854531
http://dx.doi.org/10.1155/2018/9864285

Ejemplares similares